Thrivent Financial For Lutherans Exelixis, Inc. Transaction History
Thrivent Financial For Lutherans
- $52.6 Billion
- Q3 2024
A detailed history of Thrivent Financial For Lutherans transactions in Exelixis, Inc. stock. As of the latest transaction made, Thrivent Financial For Lutherans holds 75,684 shares of EXEL stock, worth $2.55 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
75,684
Previous 79,051
4.26%
Holding current value
$2.55 Million
Previous $1.78 Million
10.59%
% of portfolio
0.0%
Previous 0.0%
Shares
25 transactions
Others Institutions Holding EXEL
# of Institutions
503Shares Held
244MCall Options Held
2.54MPut Options Held
2.29M-
Black Rock Inc. New York, NY33.5MShares$1.13 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA29.3MShares$986 Million0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA25.4MShares$855 Million3.31% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny15.4MShares$517 Million0.63% of portfolio
-
State Street Corp Boston, MA11.4MShares$385 Million0.01% of portfolio
About EXELIXIS, INC.
- Ticker EXEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 321,832,000
- Market Cap $10.8B
- Description
- Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...